Woodline Partners’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-286,543
Closed -$2.09M 876
2022
Q4
$2.09M Sell
286,543
-1,439
-0.5% -$10.2K 0.03% 466
2022
Q3
$1.99M Sell
287,982
-38,330
-12% -$286K 0.03% 459
2022
Q2
$2.28M Sell
326,312
-154,051
-32% -$1.2M 0.04% 408
2022
Q1
$3.97M Buy
480,363
+347,925
+263% +$3.14M 0.06% 269
2021
Q4
$1.43M Buy
+132,438
New +$1.43M 0.02% 478

Other funds holding AMYT

Woodline Partners's AMYT Position: Q1 2023 in Review

Woodline Partners sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 286,543 shares — an estimated $2.09M sold.

Woodline Partners first reported a position in AMYT in Q4 2021 and held it in 5 quarters. The position peaked at $3.97M in Q1 2022. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

  • Woodline Partners reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Woodline Partners sold 286,543 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $2.09M.
  • Woodline Partners first reported a position in Amryt Pharma plc American Depositary Shares in Q4 2021 and held it in 5 quarters.
  • Woodline Partners's Amryt Pharma plc American Depositary Shares position peaked at $3.97M in Q1 2022.
  • 79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.

Based on Woodline Partners's 13F filing for Q1 2023, filed 15 May 2023.